| Names | |
|---|---|
|
IUPAC name
2-Amino-2-methylpropanoic acid
|
|
| Other names
α-Aminoisobutyric acid
2-Methylalanine |
|
| Identifiers | |
|
3D model (JSmol)
|
|
| ChEBI | |
| ChemSpider | |
| DrugBank | |
| ECHA InfoCard | 100.000.495 |
| EC Number | 200-544-0 |
| KEGG | |
|
PubChem CID
|
|
|
|
|
|
| Properties | |
| C4H9NO2 | |
| Molar mass | 103.12 g/mol |
| Appearance | white crystalline powder |
| Density | 1.09 g/mL |
| Boiling point | 204.4 °C (399.9 °F; 477.5 K) |
| soluble | |
| Acidity (pKa) | 2.36 (carboxyl), 10.21 (amino) |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
|
|
|
| Infobox references | |
2-Aminoisobutyric acid, or α-aminoisobutyric acid (AIB) or α-methylalanine or 2-methylalanine, is an amino acid with the structural formula is H2N-C(CH3)2-COOH. It is contained in some antibiotics of fungal origin, e.g. alamethicin and some lantibiotics. It is not one of the proteinogenic amino acids and is rather rare in nature (cf. non-proteinogenic amino acids).
In the laboratory, 2-aminoisobutyric acid may be prepared from acetone cyanohydrin, by reaction with ammonia followed by hydrolysis. Industrial scale synthesis can be achieved by the selective hydroamination of methacrylic acid.
2-Aminoisobutyric acid is not one of the proteinogenic amino acids and is rather rare in nature (cf. non-proteinogenic amino acids). It is a strong helix inducer in peptides. Oligomers of AIB form 310 helices. BAIBA, or 3-aminoisobutyric acid, is found as a normal metabolite of skeletal muscle in 2014. The plasma concentrations are increased in human by exercise. The production is likely a result of enhanced mitochondrial activity as the increase is also observed in the muscle of PGC-1a overexpression mice. BAIBA is proposed as protective factor against metabolic disorder since it can induce brown fat function.
Several reports have confirmed the compatibility of 2-Aminoisobutyric acid with ribosomal elongation of peptide synthesis. Katoh et al. used flexizymes and an engineered a tRNA body to enhance the affinity of aminoacylated AIB-tRNA species to elongation factor-P. The result was an increased incorporation of AIB into peptides in a cell free translation system. Iqbal et al. used an alternative approach of creating an editing deficient valine tRNA-ligase to synthesize aminoacylated AIB-tRNAVal. The aminoacylated tRNA was subsequently used in a cell-free translation system to yield AIB-containing peptides.